Beijing's Changping unleashes high tech creativity

By Zhang Jiaqi
0 Comment(s)Print E-mail China.org.cn, February 14, 2022
Adjust font size:
A hydrogen-fueled bus developed and manufactured by SPIC, Feb. 11, 2022. Some 150 such buses are in use for the Winter Olympics in downtown Beijing and suburban Yanqing. [Photo by Zhang Jiaqi/China.org.cn]

While Beijing is presenting the world with a green Winter Olympics, hydrogen fuel is playing its part. Some 150 hydrogen-powered buses developed by the State Power Investment Corporation Limited (SPIC) are currently in use for the Games in downtown Beijing and suburban Yanqing.

Zhang Yinguang, general manager of SPIC Hydrogen Energy Co., Ltd., introduced the company's achievements during a visit to SPIC by 40 journalists from over two dozen Chinese and foreign media outlets. Located in the Future Science City in Beijing's northwestern Changping district, SPIC is just one of over 500 energy companies located here in the "energy valley."

In recent years, Changping district has seen continued growth in high tech creativity. Over the past decade, the Future Science City in the district has expanded from around 10 square kilometers to over 170 square kilometers, bringing together increasingly innovative market entities.

So far, the buses developed and manufactured by SPIC have performed well in terms of both technological reliability and service quality, boosting the industry's confidence in popularizing the use of hydrogen energy, said Zhang, adding that "the Winter Olympics will be of milestone significance to the development of hydrogen energy."

According to Fan Jihong, head of SPIC Research Institute, by the end of last year, SPIC's installed capacity of new energy was 79.36 million kilowatts, ranking first in the world.

Besides the energy companies, life science research institutes, labs and companies are also clustered in the Future Science City, forming a "life valley."

Beijing InnoCare Pharma is one of over 500 innovation-based companies in the "life valley," and its proprietary drug "orelabrutinib" was approved for marketing in China and included in the national reimbursement drug list last December, benefiting lymphoma patients.

According to Lu Chunhua, senior director of corporate communication at InnoCare, the company has submitted 224 patent applications and been granted 37 patent licenses in China and around the world since its inception in 2015.

"Innovation is always the foundation for the biotech industry, and we are happy to grow in Changping, which is a hotbed for innovation in Beijing," Lu said.

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter
主站蜘蛛池模板: 国产99久久精品一区二区| 欧美激情一区二区三区在线 | 高跟丝袜美女一级毛片| 孕交videodesexo孕交| 久久久国产乱子伦精品| 欧美va天堂在线电影| 加勒比一本大道香蕉在线视频| 男女真实无遮挡xx00动态图120秒| 成a人片亚洲日本久久| 久久亚洲国产视频| 欧美精品一区视频| 国产99在线a视频| 青娱乐国产视频| 国产成人精品久久| a级黄色一级片| 日本XXXX裸体XXXX| 久久精品道一区二区三区| 波多野结衣全部系列在线观看| 国产一卡2卡3卡4卡无卡免费视频 国产一卡2卡3卡4卡网站免费 | 老司机美女一级毛片| 国产午夜a理论毛片在线影院| 狠狠色噜噜狠狠狠狠69| 天天操天天插天天干| 久久亚洲国产精品123区| 极品国产高颜值露脸在线| 人人狠狠综合久久亚洲婷婷| 西西人体444rt高清大胆| 国产成人综合洲欧美在线| 中文网丁香综合网| 天天操天天干天天| 一级毛片免费播放视频| 曰批免费视频观看40分钟| 亚洲国产精品视频| 欧美色欧美亚洲高清在线观看| 人人添人人澡人人澡人人人人| 精品一区狼人国产在线| 国产亚洲精品无码专区| 高潮内射免费看片| 国产在线观看的| 香港经典aa毛片免费观看变态| 国产精品成人久久久久久久|